Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash Flows From Operating Activities    
Net loss $ (14,792) $ (8,639)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,540 1,749
Interest accretion 276 220
Mark to market on warrants (49) (45)
Stock-based compensation 818 990
Bad debt expense 250 499
Other gains and expenses, net 18
Other changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 2,708 (3,982)
Increase in other current assets (788) (252)
(Decrease) increase in accounts payable (1,464) 530
Decrease in accrued salaries and bonus (94) (141)
Increase in accrued liabilities 856 1,154
Increase in long-term liabilities 33 114
Net cash used in operating activities (6,673) (7,785)
Cash Flows From Investing Activity    
Purchase of property and equipment (913) (48)
Sale of property and equipment 13
Net cash used in investing activity (913) (35)
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 434 5,962
Borrowings on Line of Credit, net 400
Issuance of Series B preferred stock, net of expenses 19,537
Net cash provided by financing activities 20,371 5,962
Net increase (decrease) in cash and cash equivalents 12,785 (1,858)
Cash and cash equivalents - beginning 2,321 6,068
Cash and cash equivalents - ending $ 15,106 $ 4,210